JPRN-UMIN000012248已完成未知
Study for efficacy and safety of intravitreal injection of bevacizumab (Avastin) - Study for efficacy and safety of intravitreal injection of bevacizumab (Avastin)
ational Center for Global Health and Medicine, Kohnodai Hospital0 个研究点目标入组 20 人开始时间: 2013年11月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
Intravitreal injection of bevacizumab (avastin) has performed for five patients with retinal disease. All of five cases showed thinning of the retinal thickness. Neither general or local adverse events was found.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •history of ontraocular operation within one month ocular infection ocular inflammation
研究者
相似试验
Unknown
不适用
Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.NCT01707745Sivakami A Pai50
Unknown
2 期
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of PrematurityRetinopathy of PrematurityNCT00622726The University of Texas Health Science Center, Houston150
已完成
不适用
Bevacizumab therapy for retinopathy of prematurityIntraocular neovascularizationJPRN-jRCTs051180175Ohnaka Masayuki21
撤回
3 期
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)Cystoid Macular EdemaNCT00406172Asociación para Evitar la Ceguera en México
Unknown
不适用
The Effectiveness of Intravitreal Avastin Injection for CRVOCentral Retinal Vein OcclusionNCT01678248Ziv Hospital68